Almost a decade ago a study demonstrating regression of atherosclerosis with apo A-1 Milano caused tremendous excitement, but the recombinant product has not yet undergone further research or commercial development.

FORBES: Early Look: New Methods To Enhance Cholesterol Efflux

Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.

FORBES: Anti-Vaccine Activists Apparently Immune To Science

Even a regression with lots of controls, even propensity score analysis, is insufficient in this area of study.

FORBES: Why Medicaid is a Humanitarian Catastrophe